精密医療における人工知能の2030年までの市場予測： 提供、技術、用途、地域別に世界市場を分析

Stratistics MRCによると、精密医療における人工知能の世界市場は2023年に17億3,000万米ドルを占め、予測期間中にCAGR 33.8％で成長し、2030年には133億米ドルに達すると予測されています。

精密医療における人工知能（AI）には、個別化医療を開発するために個人に関するゲノムデータを使用することが含まれます。このデータにより、患者の治療計画を作成することが可能になります。医療における人工知能（AI）は、アルゴリズムとソフトウェアの助けを借りて人間の認知を近似することにより、複雑な医療データを分析するために使用されます。AI技術は、このプロセスをより迅速かつ安価にするのに役立ち、ひいては製薬会社やバイオテクノロジー会社の効率を向上させることが期待されます。

米国立衛生研究所（NIH）の報告書によると、2023年には米国内だけで190万人のがん患者が新たに発生し、60万9820人が死亡すると予測されています。したがって、腫瘍学におけるAIの統合は、がんのより正確で迅速な診断に貢献し、患者の転帰の向上につながると期待されます。

がんの有病率の増加

がんの罹患率は上昇を続けており、より効果的で正確な治療戦略が必要とされています。高度なアルゴリズムと機械学習機能を持つAIは、がんの診断、予後、個別化治療の複雑さに取り組む強力なツールとして登場しました。AIは画像解析を通じてがんの診断に大きな影響を及ぼし、がんや転移の非常に正確な早期発見に役立っています。さらに、AI主導の予測モデリングは、病気の転帰や様々な治療に対する患者の反応を予測するのに役立ち、オーダーメイドで最適化された治療アプローチを促進します。AIは、患者が最も適切で効果的な治療を受けられるようにし、最終的には生存率を向上させ、がん治療全体の質を高める。

高コスト

精密医療のためのAI技術の開発と展開には、研究、データ収集、アルゴリズム開発、計算リソース、専門的な専門知識など、多額の費用がかかります。コスト集約的なプロセスには、最先端のコンピューティング・インフラの構築と維持、膨大なヘルスケアデータの評価、AIモデルの開発などが含まれます。このような経済的障壁は、アクセシビリティとアフォーダビリティに課題をもたらし、精密医療におけるAIの普及と実装を制限し、最終的には、ヘルスケアの転帰と個別化治療に革命をもたらす可能性に影響を及ぼします。

技術の進歩

AIは目覚ましい進歩を遂げ、機械学習、深層学習、自然言語処理、予測分析を活用し、精密医療の文脈における医療データの分析・活用方法に革命をもたらしています。AIを搭載したツールは、診断、創薬、患者のリスク評価、治療の最適化を支援し、全体的な患者ケアと転帰を向上させることができます。さらに、AIアルゴリズムとモデルの継続的な強化は、精密医療のより正確で効率的、かつ信頼性の高いAIソリューションの創出を促進しています。テクノロジーが進化し続けるにつれて、精密医療におけるAIの能力はさらに拡大し、より効果的でタイムリーな個別化された医療介入に貢献し、最終的には医療の実践方法に革命をもたらし、世界規模で患者の転帰を改善することが期待されます。

セキュリティ・リスク

AIの統合には、遺伝子データや医療記録など、膨大な量の患者固有の情報が必要となります。この豊富な個人データは、この分野をサイバー脅威、データ侵害、不正アクセスの格好の標的にしています。このような機密情報を悪意のある攻撃から守り、厳格なプライバシー規制を確実に遵守することは、大きな課題となっています。セキュリティ侵害は患者の機密性を損ない、AIを搭載したシステムに対する信頼を損ない、ヘルスケアプロバイダーと患者の双方がこのような変革をもたらす可能性のあるテクノロジーの採用を思いとどまる可能性があります。こうした脅威が市場の成長を妨げています。

COVID-19の影響

COVID-19の流行は、精密医療市場におけるAIにプラスの影響を与えました。ヘルスケア部門は、パンデミックがもたらした問題に対処するため、AI技術の活用に一層注力するようになっています。COVID-19危機の際、AIは診断、治療法の開発、新薬の発見、患者管理などの分野で不可欠だっています。さらに、AIアルゴリズムの使用により、COVID-19症例を正確かつ迅速に診断するための膨大なデータベースの分析が可能になっています。AIを活用したソリューションは、薬剤候補を特定し、薬剤の再利用プロセスを迅速化することで、潜在的な治療薬やワクチンの開発を促進しており、これは有望な機会を生み出しています。

予測期間中、ソフトウェア・セグメントが最大となる見込み

精密医療における人工知能をベースとしたソフトウェアソリューションが、組織、ヘルスケア支払者、患者、医療提供者によって急速に採用されていることから、ソフトウェア分野が最大のシェアを占めると推定されます。また、遠隔医療、ロボット手術、臨床試験、サイバーセキュリティ、投与ミス削減、バーチャルアシスタント、臨床試験など、ヘルスケア業界におけるAI技術の応用が拡大していることも成長の要因となっています。さらに、政府や商業的な取り組みもこのセグメントの拡大を後押ししています。複数の企業が、科学的予測に関する深い知識に基づくMLアルゴリズムを使用してがんの進行を推定するソフトウェアサービスを提供しており、治療に対する反応としてがんの進行を効果的に予測するのに役立っています。

神経分野は予測期間中に最も高いCAGRが見込まれる

神経分野は、てんかん、認知症、片頭痛、アルツハイマー病、脳腫瘍などの神経疾患の有病率が上昇していることから、予測期間中に有利な成長が見込まれます。この分野の成長は、精密な治療を提供することで脳卒中に罹患した患者を治療できる人工知能に対する需要の高まりも後押ししています。AIは脳外科手術の術前、術後、術中の段階を強化します。こうした要素が、同分野の成長を後押ししています。

最大シェアの地域

北米は、健康と福祉に対する消費者の支出力が高いこと、研究開発関連の投資が急拡大していること、米国やカナダなどの国々に強力な医療インフラが存在すること、2022年の精密医療における人工知能市場で優位を占めていることなどから、予測期間中に最大の市場シェアを獲得しました。さらに、AIソフトウェアやシステムの有名メーカーが複数存在することや、スタートアップ企業のAI利用を支援する政府の取り組みが活発化していることも、この分野の成長を加速させると思われます。

CAGRが最も高い地域：

欧州は、予測期間中に収益性の高い成長を遂げると予想されます。慢性疾患の頻度上昇と高齢者人口の増加により、感染症の早期発見と強化の必要性が高まっています。この地域の国々は、ヘルスケアの成果を高めるためにAI技術を積極的に取り入れています。AIは膨大な医療データセットの解釈、治療の個別化、創薬プロセスの最適化に活用されています。さまざまな企業が、他社よりも競争優位に立つための戦略を実施しています。さらに、学界、産業界、ヘルスケアプロバイダー間の協力的な取り組みが精密医療におけるAIの成長を促進し、欧州をこの変革的なヘルスケア領域における重要なプレーヤーとして位置づけています。

無料のカスタマイズ提供：

本レポートをご購読のお客様には、以下の無料カスタマイズオプションのいずれかをご利用いただけます：

• 企業プロファイル
  • 追加市場プレーヤーの包括的プロファイリング（3社まで）
  • 主要企業のSWOT分析（3社まで）
• 地域セグメンテーション
  • 顧客の関心に応じた主要国の市場推計・予測・CAGR（注：フィージビリティチェックによる）
• 競合ベンチマーキング
  • 製品ポートフォリオ、地理的プレゼンス、戦略的提携に基づく主要企業のベンチマーキング

目次

第1章 エグゼクティブサマリー

第2章 序文

• 概要
• ステークホルダー
• 調査範囲
• 調査手法
  • データマイニング
  • データ分析
  • データ検証
  • 調査アプローチ
• 調査ソース
  • 1次調査ソース
  • 2次調査ソース
  • 前提条件

第3章 市場動向分析

• 促進要因
• 抑制要因
• 機会
• 脅威
• 技術分析
• アプリケーション分析
• 新興市場
• 新型コロナウイルス感染症（COVID-19）の影響

第4章 ポーターのファイブフォース分析

• 供給企業の交渉力
• 買い手の交渉力
• 代替品の脅威
• 新規参入業者の脅威
• 競争企業間の敵対関係

第5章 プレシジョン・メディシン市場における世界の人工知能：提供内容別

• ハードウェア
• サービス
• ソフトウェア

第6章 精密医療市場における世界の人工知能：テクノロジー別

• 機械学習
• コンテキストアウェアコンピューティング
• 自然言語処理
• コンピュータビジョン
• 問い合わせ方法
• ディープラーニング

第7章 精密医療市場における世界の人工知能：アプリケーション別

• 腫瘍学
• 神経内科
• 心臓病学
• 呼吸器系
• 眼科
• 腎臓学
• 耳鼻咽喉科
• その他の用途

第8章 精密医療市場における世界の人工知能：地域別

• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • イタリア
  • フランス
  • スペイン
  • その他欧州
• アジア太平洋地域
  • 日本
  • 中国
  • インド
  • オーストラリア
  • ニュージーランド
  • 韓国
  • その他アジア太平洋地域
• 南米
  • アルゼンチン
  • ブラジル
  • チリ
  • その他南米
• 中東とアフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • カタール
  • 南アフリカ
  • その他中東とアフリカ

第9章 主な発展

• 契約、パートナーシップ、コラボレーション、合弁事業
• 買収と合併
• 新製品の発売
• 事業拡大
• その他の主要戦略

第10章 企業プロファイル

• BioXcel Therapeutics Inc.
• Intel Corporation
• Insilico Medicine
• Microsoft Corporation
• NVIDIA Corporation
• Sensely, Inc.
• Alphabet Inc.（Google）
• IBM
• AceTech
• Enlitic Inc
• GE Healthcare
• AstraZeneca
• Sanofi
• Microsoft Corporation
• Welletok Inc.
• General Vision
• Atomwise Inc.
• Caption Health
• Zephyr AI
• Berg Health

List of Tables

• Table 1 Global Artificial Intelligence In Precision Medicine Market Outlook, By Region (2021-2030) ($MN)
• Table 2 Global Artificial Intelligence In Precision Medicine Market Outlook, By Offering
• Table 3 Global Artificial Intelligence In Precision Medicine Market Outlook, By Hardware
• Table 4 Global Artificial Intelligence In Precision Medicine Market Outlook, By Services
• Table 5 Global Artificial Intelligence In Precision Medicine Market Outlook, By Software
• Table 6 Global Artificial Intelligence In Precision Medicine Market Outlook, By Technology
• Table 7 Global Artificial Intelligence In Precision Medicine Market Outlook, By Machine Learning
• Table 8 Global Artificial Intelligence In Precision Medicine Market Outlook, By Context-aware Computing
• Table 9 Global Artificial Intelligence In Precision Medicine Market Outlook, By Natural Language Processing
• Table 10 Global Artificial Intelligence In Precision Medicine Market Outlook, By Computer Vision
• Table 11 Global Artificial Intelligence In Precision Medicine Market Outlook, By Querying Method
• Table 12 Global Artificial Intelligence In Precision Medicine Market Outlook, By Deep Learning
• Table 13 Global Artificial Intelligence In Precision Medicine Market Outlook, By Application
• Table 14 Global Artificial Intelligence In Precision Medicine Market Outlook, By Oncology
• Table 15 Global Artificial Intelligence In Precision Medicine Market Outlook, By Neurology
• Table 16 Global Artificial Intelligence In Precision Medicine Market Outlook, By Cardiology
• Table 17 Global Artificial Intelligence In Precision Medicine Market Outlook, By Respiratory
• Table 18 Global Artificial Intelligence In Precision Medicine Market Outlook, By Ophthalmology
• Table 19 Global Artificial Intelligence In Precision Medicine Market Outlook, By Nephrology
• Table 20 Global Artificial Intelligence In Precision Medicine Market Outlook, By Otorhinolaryngology
• Table 21 Global Artificial Intelligence In Precision Medicine Market Outlook, By Other Applications
• Table 22 North America Artificial Intelligence In Precision Medicine Market Outlook, By Country (2021-2030) ($MN)
• Table 23 North America Artificial Intelligence In Precision Medicine Market Outlook, By Offering (2021-2030) ($MN)
• Table 24 North America Artificial Intelligence In Precision Medicine Market Outlook, By Hardware (2021-2030) ($MN)
• Table 25 North America Artificial Intelligence In Precision Medicine Market Outlook, By Services (2021-2030) ($MN)
• Table 26 North America Artificial Intelligence In Precision Medicine Market Outlook, By Software (2021-2030) ($MN)
• Table 27 North America Artificial Intelligence In Precision Medicine Market Outlook, By Technology (2021-2030) ($MN)
• Table 28 North America Artificial Intelligence In Precision Medicine Market Outlook, By Machine Learning (2021-2030) ($MN)
• Table 29 North America Artificial Intelligence In Precision Medicine Market Outlook, By Context-aware Computing (2021-2030) ($MN)
• Table 30 North America Artificial Intelligence In Precision Medicine Market Outlook, By Natural Language Processing (2021-2030) ($MN)
• Table 31 North America Artificial Intelligence In Precision Medicine Market Outlook, By Computer Vision (2021-2030) ($MN)
• Table 32 North America Artificial Intelligence In Precision Medicine Market Outlook, By Querying Method (2021-2030) ($MN)
• Table 33 North America Artificial Intelligence In Precision Medicine Market Outlook, By Deep Learning (2021-2030) ($MN)
• Table 34 North America Artificial Intelligence In Precision Medicine Market Outlook, By Application (2021-2030) ($MN)
• Table 35 North America Artificial Intelligence In Precision Medicine Market Outlook, By Oncology (2021-2030) ($MN)
• Table 36 North America Artificial Intelligence In Precision Medicine Market Outlook, By Neurology (2021-2030) ($MN)
• Table 37 North America Artificial Intelligence In Precision Medicine Market Outlook, By Cardiology (2021-2030) ($MN)
• Table 38 North America Artificial Intelligence In Precision Medicine Market Outlook, By Respiratory (2021-2030) ($MN)
• Table 39 North America Artificial Intelligence In Precision Medicine Market Outlook, By Ophthalmology (2021-2030) ($MN)
• Table 40 North America Artificial Intelligence In Precision Medicine Market Outlook, By Nephrology (2021-2030) ($MN)
• Table 41 North America Artificial Intelligence In Precision Medicine Market Outlook, By Otorhinolaryngology (2021-2030) ($MN)
• Table 42 North America Artificial Intelligence In Precision Medicine Market Outlook, By Other Applications (2021-2030) ($MN)
• Table 43 Europe Artificial Intelligence In Precision Medicine Market Outlook, By Country (2021-2030) ($MN)
• Table 44 Europe Artificial Intelligence In Precision Medicine Market Outlook, By Offering (2021-2030) ($MN)
• Table 45 Europe Artificial Intelligence In Precision Medicine Market Outlook, By Hardware (2021-2030) ($MN)
• Table 46 Europe Artificial Intelligence In Precision Medicine Market Outlook, By Services (2021-2030) ($MN)
• Table 47 Europe Artificial Intelligence In Precision Medicine Market Outlook, By Software (2021-2030) ($MN)
• Table 48 Europe Artificial Intelligence In Precision Medicine Market Outlook, By Technology (2021-2030) ($MN)
• Table 49 Europe Artificial Intelligence In Precision Medicine Market Outlook, By Machine Learning (2021-2030) ($MN)
• Table 50 Europe Artificial Intelligence In Precision Medicine Market Outlook, By Context-aware Computing (2021-2030) ($MN)
• Table 51 Europe Artificial Intelligence In Precision Medicine Market Outlook, By Natural Language Processing (2021-2030) ($MN)
• Table 52 Europe Artificial Intelligence In Precision Medicine Market Outlook, By Computer Vision (2021-2030) ($MN)
• Table 53 Europe Artificial Intelligence In Precision Medicine Market Outlook, By Querying Method (2021-2030) ($MN)
• Table 54 Europe Artificial Intelligence In Precision Medicine Market Outlook, By Deep Learning (2021-2030) ($MN)
• Table 55 Europe Artificial Intelligence In Precision Medicine Market Outlook, By Application (2021-2030) ($MN)
• Table 56 Europe Artificial Intelligence In Precision Medicine Market Outlook, By Oncology (2021-2030) ($MN)
• Table 57 Europe Artificial Intelligence In Precision Medicine Market Outlook, By Neurology (2021-2030) ($MN)
• Table 58 Europe Artificial Intelligence In Precision Medicine Market Outlook, By Cardiology (2021-2030) ($MN)
• Table 59 Europe Artificial Intelligence In Precision Medicine Market Outlook, By Respiratory (2021-2030) ($MN)
• Table 60 Europe Artificial Intelligence In Precision Medicine Market Outlook, By Ophthalmology (2021-2030) ($MN)
• Table 61 Europe Artificial Intelligence In Precision Medicine Market Outlook, By Nephrology (2021-2030) ($MN)
• Table 62 Europe Artificial Intelligence In Precision Medicine Market Outlook, By Otorhinolaryngology (2021-2030) ($MN)
• Table 63 Europe Artificial Intelligence In Precision Medicine Market Outlook, By Other Applications (2021-2030) ($MN)
• Table 64 Asia Pacific Artificial Intelligence In Precision Medicine Market Outlook, By Country (2021-2030) ($MN)
• Table 65 Asia Pacific Artificial Intelligence In Precision Medicine Market Outlook, By Offering (2021-2030) ($MN)
• Table 66 Asia Pacific Artificial Intelligence In Precision Medicine Market Outlook, By Hardware (2021-2030) ($MN)
• Table 67 Asia Pacific Artificial Intelligence In Precision Medicine Market Outlook, By Services (2021-2030) ($MN)
• Table 68 Asia Pacific Artificial Intelligence In Precision Medicine Market Outlook, By Software (2021-2030) ($MN)
• Table 69 Asia Pacific Artificial Intelligence In Precision Medicine Market Outlook, By Technology (2021-2030) ($MN)
• Table 70 Asia Pacific Artificial Intelligence In Precision Medicine Market Outlook, By Machine Learning (2021-2030) ($MN)
• Table 71 Asia Pacific Artificial Intelligence In Precision Medicine Market Outlook, By Context-aware Computing (2021-2030) ($MN)
• Table 72 Asia Pacific Artificial Intelligence In Precision Medicine Market Outlook, By Natural Language Processing (2021-2030) ($MN)
• Table 73 Asia Pacific Artificial Intelligence In Precision Medicine Market Outlook, By Computer Vision (2021-2030) ($MN)
• Table 74 Asia Pacific Artificial Intelligence In Precision Medicine Market Outlook, By Querying Method (2021-2030) ($MN)
• Table 75 Asia Pacific Artificial Intelligence In Precision Medicine Market Outlook, By Deep Learning (2021-2030) ($MN)
• Table 76 Asia Pacific Artificial Intelligence In Precision Medicine Market Outlook, By Application (2021-2030) ($MN)
• Table 77 Asia Pacific Artificial Intelligence In Precision Medicine Market Outlook, By Oncology (2021-2030) ($MN)
• Table 78 Asia Pacific Artificial Intelligence In Precision Medicine Market Outlook, By Neurology (2021-2030) ($MN)
• Table 79 Asia Pacific Artificial Intelligence In Precision Medicine Market Outlook, By Cardiology (2021-2030) ($MN)
• Table 80 Asia Pacific Artificial Intelligence In Precision Medicine Market Outlook, By Respiratory (2021-2030) ($MN)
• Table 81 Asia Pacific Artificial Intelligence In Precision Medicine Market Outlook, By Ophthalmology (2021-2030) ($MN)
• Table 82 Asia Pacific Artificial Intelligence In Precision Medicine Market Outlook, By Nephrology (2021-2030) ($MN)
• Table 83 Asia Pacific Artificial Intelligence In Precision Medicine Market Outlook, By Otorhinolaryngology (2021-2030) ($MN)
• Table 84 Asia Pacific Artificial Intelligence In Precision Medicine Market Outlook, By Other Applications (2021-2030) ($MN)
• Table 85 South America Artificial Intelligence In Precision Medicine Market Outlook, By Country (2021-2030) ($MN)
• Table 86 South America Artificial Intelligence In Precision Medicine Market Outlook, By Offering (2021-2030) ($MN)
• Table 87 South America Artificial Intelligence In Precision Medicine Market Outlook, By Hardware (2021-2030) ($MN)
• Table 88 South America Artificial Intelligence In Precision Medicine Market Outlook, By Services (2021-2030) ($MN)
• Table 89 South America Artificial Intelligence In Precision Medicine Market Outlook, By Software (2021-2030) ($MN)
• Table 90 South America Artificial Intelligence In Precision Medicine Market Outlook, By Technology (2021-2030) ($MN)
• Table 91 South America Artificial Intelligence In Precision Medicine Market Outlook, By Machine Learning (2021-2030) ($MN)
• Table 92 South America Artificial Intelligence In Precision Medicine Market Outlook, By Context-aware Computing (2021-2030) ($MN)
• Table 93 South America Artificial Intelligence In Precision Medicine Market Outlook, By Natural Language Processing (2021-2030) ($MN)
• Table 94 South America Artificial Intelligence In Precision Medicine Market Outlook, By Computer Vision (2021-2030) ($MN)
• Table 95 South America Artificial Intelligence In Precision Medicine Market Outlook, By Querying Method (2021-2030) ($MN)
• Table 96 South America Artificial Intelligence In Precision Medicine Market Outlook, By Deep Learning (2021-2030) ($MN)
• Table 97 South America Artificial Intelligence In Precision Medicine Market Outlook, By Application (2021-2030) ($MN)
• Table 98 South America Artificial Intelligence In Precision Medicine Market Outlook, By Oncology (2021-2030) ($MN)
• Table 99 South America Artificial Intelligence In Precision Medicine Market Outlook, By Neurology (2021-2030) ($MN)
• Table 100 South America Artificial Intelligence In Precision Medicine Market Outlook, By Cardiology (2021-2030) ($MN)
• Table 101 South America Artificial Intelligence In Precision Medicine Market Outlook, By Respiratory (2021-2030) ($MN)
• Table 102 South America Artificial Intelligence In Precision Medicine Market Outlook, By Ophthalmology (2021-2030) ($MN)
• Table 103 South America Artificial Intelligence In Precision Medicine Market Outlook, By Nephrology (2021-2030) ($MN)
• Table 104 South America Artificial Intelligence In Precision Medicine Market Outlook, By Otorhinolaryngology (2021-2030) ($MN)
• Table 105 South America Artificial Intelligence In Precision Medicine Market Outlook, By Other Applications (2021-2030) ($MN)
• Table 106 Middle East & Africa Artificial Intelligence In Precision Medicine Market Outlook, By Country (2021-2030) ($MN)
• Table 107 Middle East & Africa Artificial Intelligence In Precision Medicine Market Outlook, By Offering (2021-2030) ($MN)
• Table 108 Middle East & Africa Artificial Intelligence In Precision Medicine Market Outlook, By Hardware (2021-2030) ($MN)
• Table 109 Middle East & Africa Artificial Intelligence In Precision Medicine Market Outlook, By Services (2021-2030) ($MN)
• Table 110 Middle East & Africa Artificial Intelligence In Precision Medicine Market Outlook, By Software (2021-2030) ($MN)
• Table 111 Middle East & Africa Artificial Intelligence In Precision Medicine Market Outlook, By Technology (2021-2030) ($MN)
• Table 112 Middle East & Africa Artificial Intelligence In Precision Medicine Market Outlook, By Machine Learning (2021-2030) ($MN)
• Table 113 Middle East & Africa Artificial Intelligence In Precision Medicine Market Outlook, By Context-aware Computing (2021-2030) ($MN)
• Table 114 Middle East & Africa Artificial Intelligence In Precision Medicine Market Outlook, By Natural Language Processing (2021-2030) ($MN)
• Table 115 Middle East & Africa Artificial Intelligence In Precision Medicine Market Outlook, By Computer Vision (2021-2030) ($MN)
• Table 116 Middle East & Africa Artificial Intelligence In Precision Medicine Market Outlook, By Querying Method (2021-2030) ($MN)
• Table 117 Middle East & Africa Artificial Intelligence In Precision Medicine Market Outlook, By Deep Learning (2021-2030) ($MN)
• Table 118 Middle East & Africa Artificial Intelligence In Precision Medicine Market Outlook, By Application (2021-2030) ($MN)
• Table 119 Middle East & Africa Artificial Intelligence In Precision Medicine Market Outlook, By Oncology (2021-2030) ($MN)
• Table 120 Middle East & Africa Artificial Intelligence In Precision Medicine Market Outlook, By Neurology (2021-2030) ($MN)
• Table 121 Middle East & Africa Artificial Intelligence In Precision Medicine Market Outlook, By Cardiology (2021-2030) ($MN)
• Table 122 Middle East & Africa Artificial Intelligence In Precision Medicine Market Outlook, By Respiratory (2021-2030) ($MN)
• Table 123 Middle East & Africa Artificial Intelligence In Precision Medicine Market Outlook, By Ophthalmology (2021-2030) ($MN)
• Table 124 Middle East & Africa Artificial Intelligence In Precision Medicine Market Outlook, By Nephrology (2021-2030) ($MN)
• Table 125 Middle East & Africa Artificial Intelligence In Precision Medicine Market Outlook, By Otorhinolaryngology (2021-2030) ($MN)
• Table 126 Middle East & Africa Artificial Intelligence In Precision Medicine Market Outlook, By Other Applications (2021-2030) ($MN)

According to Stratistics MRC, the Global Artificial Intelligence In Precision Medicine Market is accounted for $1.73 billion in 2023 and is expected to reach $13.3 billion by 2030 growing at a CAGR of 33.8% during the forecast period. Artificial intelligence (AI) in precision medicine involves the use of genomic data about an individual to develop personalised medicine. With this data, it is possible to create treatment plans for patients. Artificial intelligence (AI) in medicine is used to analyse complex medical data by approximating human cognition with the help of algorithms and software. AI technology can help make this process faster and cheaper, which in turn is expected to improve the efficiency of pharmaceutical and biotechnology companies.

According to the National Institutes of Health (NIH) report, in 2023, 1.9 million new cancer cases and 609,820 cancer deaths are projected to occur in the U.S. only. Therefore, integration of AI in oncology is expected to contribute to more accurate and faster diagnosis of cancer, leading to enhanced patient outcomes.

Market Dynamics:

Driver:

Increasing prevalence of cancer

Cancer incidence rates continue to escalate, necessitating more effective and precise treatment strategies. AI, with its advanced algorithms and machine learning capabilities, has emerged as a potent tool to tackle the complexities of cancer diagnosis, prognosis, and personalised treatment. AI has a significant impact on the diagnosis of cancer through image analysis, assisting in the very accurate early detection of cancers and metastases. Moreover, AI-driven predictive modelling helps anticipate disease outcomes and patient responses to various treatments, facilitating tailored and optimised therapeutic approaches. AI ensures that patients receive the most appropriate and effective treatments, ultimately improving survival rates and enhancing the overall quality of cancer care.

Restraint:

High cost

The development and deployment of AI technologies for precision medicine entail substantial expenses in terms of research, data collection, algorithm development, computational resources, and specialised expertise. The cost-intensive processes include building and maintaining cutting-edge computing infrastructure, evaluating vast amounts of healthcare data, and developing AI models. These financial barriers pose challenges in accessibility and affordability, limiting the widespread adoption and implementation of AI in precision medicine and ultimately affecting its potential to revolutionise healthcare outcomes and personalised treatments.

Opportunity:

Technological advancements

AI has evolved with remarkable progress, leveraging machine learning, deep learning, natural language processing, and predictive analytics to revolutionise how medical data is analysed and utilised in the context of precision medicine. AI-powered tools can assist in diagnosis, drug discovery, patient risk assessment, and treatment optimisation, enhancing overall patient care and outcomes. Moreover, the continuous enhancement of AI algorithms and models is fostering the creation of more accurate, efficient, and reliable AI solutions for precision medicine. As technology continues to evolve, the capabilities of AI in precision medicine are expected to expand further, contributing to more effective, timely, and personalised healthcare interventions, ultimately revolutionising the way medicine is practiced and improving patient outcomes on a global scale.

Threat:

Security risks

The integration of AI requires vast amounts of patient-specific information, including genetic data and medical records. This abundance of personal data makes the sector a prime target for cyber threats, data breaches, and unauthorised access. Protecting this sensitive information from malicious attacks and ensuring compliance with stringent privacy regulations poses a significant challenge. Security breaches can compromise patient confidentiality, erode trust in AI-powered systems, and deter both healthcare providers and patients from adopting these potentially transformative technologies. These threats are hampering market growth.

COVID-19 Impact

The COVID-19 pandemic had a positive impact on AI in the precision medicine market. The healthcare sector had noticed a greater focus on using AI technologies to deal with the problems the pandemic had brought up. During the COVID-19 crisis, AI was essential in areas including diagnosis, the development of treatments, the discovery of new drugs, and patient management. Additionally, the use of AI algorithms has made it possible to analyse huge databases for a precise and quick diagnosis of COVID-19 cases. AI-powered solutions have facilitated the development of potential therapeutics and vaccines by identifying drug candidates and expediting the drug repurposing process, this has produced promising opportunities.

The Software segment is expected to be the largest during the forecast period

The Software segment is estimated to hold the largest share, due to a rapid adoption of software solutions based on artificial intelligence in precision medicine by organisations, healthcare payers, patients, and providers. The growth is also attributable to the expanding applications of AI technology in the healthcare industry, including telemedicine, robotic surgery, clinical trials, cybersecurity, dosing error reduction, virtual assistants, and clinical trials. Additionally, government and commercial initiatives also fuel the segment's expansion. Several companies provide software services that estimate cancer progression using an ML algorithm based on in-depth knowledge of scientific prediction, helping to effectively anticipate cancer progression as a response to therapy.

The Neurology segment is expected to have the highest CAGR during the forecast period

The Neurology segment is anticipated to have lucrative growth during the forecast period, due to the rising prevalence of neurological conditions such as epilepsy, dementia, migraines, Alzheimer's, and brain tumours. Growth in the sector is also being fuelled as rising demand for artificial intelligence which is able to treat patients affected by strokes by providing precision treatment. AI enhances brain surgery's preoperative, postoperative, and intraoperative phases. These elements are propelling segment growth.

Region with largest share:

North America commanded the largest market share during the extrapolated period due to the region's high consumer spending power on their health and well-being, rapid growth in investment associated with research and development-related activities, the presence of a strong healthcare infrastructure in countries like the United States and Canada, and its dominance in the market for artificial intelligence in precision medicine in 2022. Moreover, the existence of multiple well-known manufacturers of AI software and systems, as well as greater government initiatives to support start-up's usage of AI, will also hasten the growth of the sector.

Region with highest CAGR:

Europe is expected to witness profitable growth over the projection period. The need for enhancing and discovering infections in their early stages is rising as a result of the rising frequency of chronic diseases and the growing older population. Countries within the region are actively embracing AI technologies to enhance healthcare outcomes. AI is being utilised to interpret vast medical datasets, personalise treatments, and optimise drug discovery processes. Various companies are implementing strategies to gain a competitive advantage over others. Additionally, collaborative efforts among academia, industry, and healthcare providers are fostering the growth of AI in precision medicine, positioning Europe as a key player in this transformative healthcare domain.

Key players in the market:

Some of the key players in the Artificial Intelligence In Precision Medicine Market include: BioXcel Therapeutics Inc., Intel Corporation, Insilico Medicine, Microsoft Corporation, NVIDIA Corporation, Sensely, Inc., Alphabet Inc. (Google), IBM, AceTech, Enlitic Inc, GE Healthcare, AstraZeneca, Sanofi, Microsoft Corporation, Welletok Inc., General Vision, Atomwise Inc., Caption Health, Zephyr AI and Berg Health .

Key Developments:

In March 2023, Enlitic, Inc. announced the launch of Enlitic Curie 1.3, an AI-based platform that hosts Curie|ENCOG and Curie|ENDEX applications. This launch makes it easier for radiology departments to improve department-wide workflows.

In November 2022, Google partnered with iCAD, Inc. The collaboration aims to improve breast cancer detection and risk assessment in the short term. Furthermore, the partnership would focus on increasing connectivity to mammography technology via cloud-based solutions.

In September 2022, NVIDIA announced collaboration with Harvard and MIT's Broad Institute. By bringing NVIDIA's computing and AI tools to the institute's Terra cloud platform, the partnership aims to assist academic researchers and pharmaceutical companies in gaining AI-enabled computing power to extract large quantities of healthcare data.

In September 2022, GE Healthcare launched an artificial intelligence-powered Cath lab, Optima IGS 320. The release is expected to offer intelligent imaging to assist patients and cardiologists with personalized therapy protocols.

In August 2022, Sanofi and Atomwise joined a partnership. As per this collaboration, the companies targeted to make the development of drug discovery more cost-effective and effective.

Offerings Covered:

• Hardware
• Services
• Software

Technologies Covered:

• Machine Learning
• Context-aware Computing
• Natural Language Processing
• Computer Vision
• Querying Method
• Deep Learning

Applications Covered:

• Oncology
• Neurology
• Cardiology
• Respiratory
• Ophthalmology
• Nephrology
• Otorhinolaryngology
• Other Applications

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

• 2.1 Abstract
• 2.2 Stake Holders
• 2.3 Research Scope
• 2.4 Research Methodology
  • 2.4.1 Data Mining
  • 2.4.2 Data Analysis
  • 2.4.3 Data Validation
  • 2.4.4 Research Approach
• 2.5 Research Sources
  • 2.5.1 Primary Research Sources
  • 2.5.2 Secondary Research Sources
  • 2.5.3 Assumptions

3 Market Trend Analysis

• 3.1 Introduction
• 3.2 Drivers
• 3.3 Restraints
• 3.4 Opportunities
• 3.5 Threats
• 3.6 Technology Analysis
• 3.7 Application Analysis
• 3.8 Emerging Markets
• 3.9 Impact of Covid-19

4 Porters Five Force Analysis

• 4.1 Bargaining power of suppliers
• 4.2 Bargaining power of buyers
• 4.3 Threat of substitutes
• 4.4 Threat of new entrants
• 4.5 Competitive rivalry

5 Global Artificial Intelligence In Precision Medicine Market, By Offering

• 5.1 Introduction
• 5.2 Hardware
• 5.3 Services
• 5.4 Software

6 Global Artificial Intelligence In Precision Medicine Market, By Technology

• 6.1 Introduction
• 6.2 Machine Learning
• 6.3 Context-aware Computing
• 6.4 Natural Language Processing
• 6.5 Computer Vision
• 6.6 Querying Method
• 6.7 Deep Learning

7 Global Artificial Intelligence In Precision Medicine Market, By Application

• 7.1 Introduction
• 7.2 Oncology
• 7.3 Neurology
• 7.4 Cardiology
• 7.5 Respiratory
• 7.6 Ophthalmology
• 7.7 Nephrology
• 7.8 Otorhinolaryngology
• 7.9 Other Applications

8 Global Artificial Intelligence In Precision Medicine Market, By Geography

• 8.1 Introduction
• 8.2 North America
  • 8.2.1 US
  • 8.2.2 Canada
  • 8.2.3 Mexico
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 Italy
  • 8.3.4 France
  • 8.3.5 Spain
  • 8.3.6 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 Japan
  • 8.4.2 China
  • 8.4.3 India
  • 8.4.4 Australia
  • 8.4.5 New Zealand
  • 8.4.6 South Korea
  • 8.4.7 Rest of Asia Pacific
• 8.5 South America
  • 8.5.1 Argentina
  • 8.5.2 Brazil
  • 8.5.3 Chile
  • 8.5.4 Rest of South America
• 8.6 Middle East & Africa
  • 8.6.1 Saudi Arabia
  • 8.6.2 UAE
  • 8.6.3 Qatar
  • 8.6.4 South Africa
  • 8.6.5 Rest of Middle East & Africa

9 Key Developments

• 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
• 9.2 Acquisitions & Mergers
• 9.3 New Product Launch
• 9.4 Expansions
• 9.5 Other Key Strategies

10 Company Profiling

• 10.1 BioXcel Therapeutics Inc.
• 10.2 Intel Corporation
• 10.3 Insilico Medicine
• 10.4 Microsoft Corporation
• 10.5 NVIDIA Corporation
• 10.6 Sensely, Inc.
• 10.7 Alphabet Inc. (Google)
• 10.8 IBM
• 10.9 AceTech
• 10.10 Enlitic Inc
• 10.11 GE Healthcare
• 10.12 AstraZeneca
• 10.13 Sanofi
• 10.14 Microsoft Corporation
• 10.15 Welletok Inc.
• 10.16 General Vision
• 10.17 Atomwise Inc.
• 10.18 Caption Health
• 10.19 Zephyr AI
• 10.20 Berg Health